Benchmark Holdings PLC Director and Divisional Management Changes (2662K)
April 21 2020 - 2:00AM
UK Regulatory
TIDMBMK
RNS Number : 2662K
Benchmark Holdings PLC
21 April 2020
21 April 2020
Benchmark Holdings plc
("Benchmark" or the "Company")
Director and Divisional Management Changes
Benchmark Holdings, the aquaculture genetics, health and
nutrition business, announces that Alex Raeber is stepping down as
Chief Scientific Officer (CSO) and a Director of the Company with
effect from 31 July 2020. Since joining Benchmark in 2018, Alex has
played an instrumental role in the execution of the Company's new
strategy, leading the review and streamlining of the product
pipeline, the integration of Benchmark's innovation teams and the
reorganisation of the Group's in-house trial facilities. Having
completed these critical projects and as the Company moves from an
R&D investment phase into commercial execution, Alex has
decided that this is the right time to pursue new challenges.
The Company also announces that Philippe Léger has decided to
retire from his current position in Benchmark from 1 July. Philippe
started his career in 1979 at the University of Ghent as a research
scientist, before joining the spin-off company that became INVE,
now Benchmark's Advanced Nutrition division. Philippe led Advanced
Nutrition until he turned 65 handing over his position to Athene
Blakeman as Head of Advanced Nutrition in July 2019. Following the
resignation of Malcolm Pye as Benchmark's CEO in 2019, Philippe
agreed to extend his service leading the executive management team
and supporting Peter George, Executive Chairman. Having completed
the handover in Advanced Nutrition and following the appointment of
incoming CEO, Trond Williksen from 1 June 2020, Philippe has
decided it is the right time to pursue new projects.
Peter George commented:
"On behalf of the Board I would like to thank Alex and Philippe
for their important contributions to Benchmark, particularly the
roles they have played in the new strategy and restructuring we
initiated in 2019. We wish them success in their future
endeavours."
Enquiries:
Benchmark Holdings PLC benchmarkplc.com/investors
Septima Maguire, CFO +44 (0)20 3696 0630
Ivonne Cantu, Investor Relations
Numis Securities
Freddie Barnfield, Duncan Monteith (Nominated
Adviser) +44 (0)20 7260 1000
James Black (Corporate Broking)
MHP Communications
Katie Hunt / Reg Hoare / Alistair de Kare-Silver +44 (0)20 3128 8742
About Benchmark Holdings PLC
Benchmark's mission is to enable food producers to improve their
sustainability and profitability.
We bring together biology and technology, to develop innovative
products which improve yield, quality and animal health and welfare
for our customers. We do this by improving the genetic make-up,
health and nutrition of their stock - from broodstock and hatchery
through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions,
including salmon eggs, live feed (Artemia), diets and probiotics
and sea lice treatments. Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAIMMLTMTJTBRM
(END) Dow Jones Newswires
April 21, 2020 02:00 ET (06:00 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From Jul 2023 to Jul 2024